Trump announces a 100% tariff on certain patented drugs, aiming to boost U.S. pharmaceutical production and negotiate lower prices.

The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower their U.S. drug prices.

Drug companies that commit to moving production to the U.S. will face a 20% tariff and no tariff if they also agree to lower prices.